← All stocks

Vyome Holdings, Inc

HIND Net selling
CIK 0001427570 #5123 in the set updated 19 Sep 2026
Bought (120 mo)
$7.13M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$16.13M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$16.13M
63 of 63 sales
Net
−$9.00M
−$9.00M against sales at will

By person

32 insiders · 104 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
ARMISTICE CAPITAL, LLC entity
10% owner
$14.23M (12)
−$14.23M
14,446,692
$3.61M
+50.2%
DOMAIN PARTERS VII L P
10% owner
$4.00M (2)
+$4.00M
813,433
$203.36K
INTERWEST PARTNERS X LP entity
10% owner
$2.10M (2)
+$2.10M
380,224
$95.06K
Bandy Barton P.
President and CEO
$1.02M (13)
−$1.02M
773,098
$193.27K
GLADNEY DAN W
Director
$598.00K (1)
−$598.00K
283,922
$70.98K
Kamdar Kim P.
Director
$351.00K (3)
+$351.00K
27,148
$6.79K
Plovanic William J.
Director
$279.15K (6)
+$279.15K
201,094
$50.27K
+852.1%
STANKOVICH THOMAS
Chief Financial Officer
$185.45K (12)
$276.10K (37)
−$90.65K
22,777
$5.69K
Rasdal Andrew P
President, CEO & Exec Chairman
$50.00K (1)
+$50.00K
528,387
$132.10K
+69.1%
Stevenson Sharon
Director
$30.00K (1)
+$30.00K
106,809
$26.70K
HOWE LESLEY H
Director
$25.00K (1)
+$25.00K
19,397
$4.85K
Brister Mark
Chief Technology Officer
$20.00K (1)
+$20.00K
103,865
$25.97K
Hussainy Nooshin
Chief Financial Officer
$20.00K (1)
+$20.00K
38,215
$9.55K
MacDonald Robert J
Chief Retail Officer
$20.00K (1)
+$20.00K
5,245
$1.31K
+2,041%
Drake Neil
VP Research and Development
$19.78K (1)
+$19.78K
79,205
$19.80K
+252.7%
Norwood Matthew
VP of Sales
$15.00K (1)
+$15.00K
1,000
$250.00
VandenBerg Amy
Chief Clinical & Reg Officer
$10.00K (1)
+$10.00K
86,764
$21.69K
Jolly Mohanjit
Director
454,456
$113.61K
BLACKFORD GARY
Director
253,429
$63.36K
MINOCHERHOMJEE ARDA PHD
Director
253,429
$63.36K
McDougal Lori Courtney
Director
253,429
$63.36K
Huang Kelly
Pres & Chief Executive Officer
184,945
$46.24K
+184.5%
DP VII ASSOCIATES LP entity
10% owner
49,570
$12.39K
Young Donald R
VP of Quality Assurance
45,369
$11.34K
+122.6%
DITTAMORE RAYMOND V
Director
27,472
$6.87K
MONDORE ROBERT H JR
VP of Operations
13,736
$3.43K
MOATAZEDI DAVID
Director
5,494
$1.37K
Wood Todd Michael
Vice President of Sales
5,494
$1.37K
Morisey Erin
VP Strategic Partnerships
1,785
$446.25
Johnson Steven Ernest
VP of Operations
1,689
$422.25
Dickey Robert IV
Chief Financial Officer
762
$190.50
Nelabhotla Venkateswarlu
President and CEO
7
$1.75

No percentages here. This company's share count has moved by a factor of 15.8 over the window, from 712,680 to 11,276,248 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Drake Neil
2 Feb 2018
VP Research and Development
Exercised, kept
4,310
$1.77
$7.63K
Drake Neil
2 Feb 2018
VP Research and Development
Exercised, kept
3,641
$0.76
$2.77K
Drake Neil
2 Feb 2018
VP Research and Development
Exercised, kept
5,746
$1.83
$10.52K
Drake Neil
2 Feb 2018
VP Research and Development
Exercised, kept
229
$1.31
$299.99
VandenBerg Amy
29 Jan 2018
VP of Reg. and Clin. Affairs
Exercised, kept
1,541
$1.31
$2.02K
VandenBerg Amy
29 Jan 2018
VP of Reg. and Clin. Affairs
Exercised, kept
1,087
$0.87
$945.69
VandenBerg Amy
29 Jan 2018
VP of Reg. and Clin. Affairs
Exercised, kept
4,022
$0.87
$3.50K

What was left out

Form 4 filings counted 199
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 63
Transactions with no price 0
Shares from compensation/vesting 19,508,179
Sales filed before the plan box existed 50
History held since 12 Oct 2016